While we keep waiting, options for fresh capital keep crossing my mind. The Nov PP looked like a desparate move, which I can only explain by a 100% focus on the technical side and the seeded hope for a breakthrough in Q3/23. Why breaking the 12-month cash in the bank rule otherwise. Hopefully the created situation was taken serious enough for the core management to tackle the financing issue as high priority. If that is the case, I believe we could finally be due for an unexpected positive surprise. If that unexpected something does not come, these are my logical alternatives for fresh capital. 

Values, dependent on market cap - big news first, followed by:

1. ATM reuse
2. PP at much higher price pre-arranged
3. A partner taking up a significant stake or similiar

Values, more independent of market cap:

4. sell an exclusive, temporary licence for one vertical (e.g. wearables)
5. sell a SPX share (e.g. 10%)

Development Work / NRE:

6. significant NRE announcement, with pre-payment terms

Mix of the above

Any additional ideas?

GLTA

bombilla